Noetik: AI-Native Biotechnology Company Closes $14 Million In Funding
By Annie Baker ● Sep 12, 2023
Noetik - an AI drug discovery company utilizing machine learning and proprietary human data to develop precision therapeutics in immuno-oncology - recently announced that it closed an oversubscribed $14M seed financing round led by DCVC, with participation from Zetta Venture Partners, 11.2 Capital, Catalio Capital Management, Epic Ventures, Intermountain Ventures, North South Ventures, Chau Khuong and CJNV BioVentures, Enveda Founder and CEO, Viswa Colluru and Hummingbird Nomads Fund, and Recursion CEO & CFO, Chris Gibson and Michael Secora.